Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Mantle Cell Lymphoma; Small Cell Variant: A Real Diagnostic Challenge. Case Presentation and Review of Literature.
Biomarkers, Tumor
Composite Lymphoma
/ diagnosis
Diagnosis, Differential
Flow Cytometry
Gene Rearrangement
Humans
Immunohistochemistry
Immunophenotyping
In Situ Hybridization, Fluorescence
Leukemia, Lymphocytic, Chronic, B-Cell
/ diagnosis
Lymphoma, Mantle-Cell
/ diagnosis
Male
Middle Aged
Oncogene Proteins, Fusion
/ genetics
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
09 Mar 2020
09 Mar 2020
Historique:
entrez:
10
3
2020
pubmed:
10
3
2020
medline:
1
12
2020
Statut:
epublish
Résumé
BACKGROUND Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and mantle cell lymphoma (MCL) both have a common origin arising from mature CD5+ B-lymphocytes. Their distinction is crucial since MCL is a considerably more aggressive disease. Composite lymphoma consisting of CLL/SLL and MCL has been rarely reported. This type of composite lymphoma may be under-diagnosed as the 2 neoplasms have many features in common, both morphologically and immunophenotypically. CASE REPORT We report the case of a 57-year-old male patient who presented with a 4-month history of recurrent abdominal pain and distention with hepatosplenomegaly. Peripheral blood showed a high leukocytes count (46.7×10³/uL) with marked lymphocytosis of 35.0×10³/uL, mostly small mature-looking, with some showing nuclear irregularities, with approximately 3% prolymphocytes. Immunophenotyping by flow cytometry and immunohistochemistry revealed 2 immunophenotypically distinct abnormal CD5+monotypic B-cell populations. Fluorescence in situ hybridization (FISH) on peripheral blood demonstrated IGH/CCND1 rearrangement consistent with t(11;14) in 65% of cells analyzed. Accordingly, based on compilation of findings from morphology, flow cytometry, immunohistochemistry, and FISH, A diagnosis of composite lymphoma consisting of MCL; small cell variant and CLL/SLL was concluded. CONCLUSIONS We describe a case of composite lymphoma of MCL (small cell variant) and CLL/SLL that emphasizes the crucial role of the multiparametric approach, including vigilant cyto-histopathologic examination, immunophenotyping by flow cytometry and immunohistochemistry, as well as genetic testing, to achieve the correct diagnosis.
Identifiants
pubmed: 32150530
pii: 921131
doi: 10.12659/AJCR.921131
pmc: PMC7083592
doi:
Substances chimiques
Biomarkers, Tumor
0
IGH-CCND1 fusion protein, human
0
Oncogene Proteins, Fusion
0
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e921131Références
Diagn Pathol. 2011 Jul 06;6:60
pubmed: 21733146
Maedica (Buchar). 2014 Jun;9(2):204-9
pubmed: 25705280
Cytometry B Clin Cytom. 2003 Jan;51(1):41-4
pubmed: 12500296
Hum Pathol. 2013 Jan;44(1):110-21
pubmed: 22944294
Acta Haematol. 2011;126(1):40-3
pubmed: 21430370
Am J Pathol. 1999 Jun;154(6):1857-66
pubmed: 10362812
Pathol Res Pract. 2017 Nov;213(11):1378-1383
pubmed: 28974340
Ann Hematol. 2012 Oct;91(10):1649-51
pubmed: 22395437
J Clin Pathol. 2015 Jun;68(6):473-8
pubmed: 25713417
Arch Pathol Lab Med. 2006 Jan;130(1):107-12
pubmed: 16390224
Acta Haematol. 2010;123(3):194-6
pubmed: 20234130
Blood. 2004 Apr 1;103(7):2795-8
pubmed: 14551145
Int J Hematol. 2013 Nov;98(5):589-96
pubmed: 24061774
Am J Clin Pathol. 2011 Apr;135(4):541-55
pubmed: 21411776
Pathol Int. 2012 Oct;62(10):690-8
pubmed: 23005596
Mod Pathol. 2011 Nov;24(11):1433-43
pubmed: 21685909
Cytometry B Clin Cytom. 2018 Jan;94(1):148-150
pubmed: 28109040
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949